Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. | Ann Hematol | 2023 | 36622392 | PubTator, text mining | PubMed |
| Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. | Nat Commun | 2023 | 36611031 | PubTator, text mining | PubMed |
| Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. | Hum Genomics | 2023 | 36604691 | PubTator, text mining | PubMed |
| Surgeons' perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey. | World J Emerg Surg | 2023 | 36597105 | PubTator, text mining | PubMed |
| The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. | Nat Cancer | 2023 | 36585449 | PubTator, text mining | PubMed |
| Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2023 | 36564459 | PubTator, text mining | PubMed |
| Clinical utility of liquid biopsy and integrative genomic profiling in early-stage and oligometastatic cancer patients treated with radiotherapy. | Br J Cancer | 2023 | 36550207 | PubTator, text mining | PubMed |
| PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study. | Asian J Androl | 2023 | 36537376 | PubTator, text mining | PubMed |
| IDH2 -Mutated Sinonasal Tumors: A Review. | Adv Anat Pathol | 2023 | 36537260 | PubTator, text mining | PubMed |
| RMI2 is a novel prognostic and predictive biomarker for breast cancer. | Cancer Med | 2023 | 36533385 | PubTator, text mining | PubMed |
| Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. | Toxicol Sci | 2023 | 36519830 | PubTator, text mining | PubMed |
Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia. | Cytotherapy | 2023 | 36481320 | PubTator, text mining | PubMed |
| Phenotypic and genotypic correlation evaluation of 148 pediatric patients with Fanconi anemia in a Chinese rare disease cohort. | Clin Chim Acta | 2023 | 36463940 | PubTator, text mining | PubMed |
| RosettaDDGPrediction for high-throughput mutational scans: From stability to binding. | Protein Sci | 2023 | 36461907 | PubTator, text mining | PubMed |
| Antecedent, behaviour, and consequence (a-b-c) of deploying the contact tracing app in response to COVID-19: Evidence from Europe. | Technol Forecast Soc Change | 2023 | 36439939 | PubTator, text mining | PubMed |
| Association of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia. | Cancer Rep (Hoboken) | 2023 | 36382570 | PubTator, text mining | PubMed |
| Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort. | Cancer Res | 2023 | 36378845 | PubTator, text mining | PubMed |
| Progress in precision therapy in pediatric oncology. | Curr Opin Pediatr | 2023 | 36377257 | PubTator, text mining | PubMed |
| Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition. | J Pathol | 2023 | 36373784 | PubTator, text mining | PubMed |
| Regorafenib with or without a programmed cell death protein 1 antibody as third-line treatment for microsatellite stable metastatic colorectal cancer. | Cancer Med | 2023 | 36373163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=31